Treatment strategies for clozapine-induced hypotension: a systematic review
Background: Clozapine is the most effective medication for treatment-refractory schizophrenia but is associated with significant adverse drug effects, including hypotension and dizziness, which have a negative impact on quality of life and treatment compliance. Available evidence for the management...
Saved in:
Main Authors: | Timothy David Tanzer (Author), Thomas Brouard (Author), Samuel Dal Pra (Author), Nicola Warren (Author), Michael Barras (Author), Steve Kisely (Author), Emily Brooks (Author), Dan Siskind (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comment on: Treatment strategies for clozapine-induced hypotension: A systematic review
by: Patrick M. Wieruszewski, et al.
Published: (2022) -
Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study
by: Jessica Spokes, et al.
Published: (2021) -
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
by: Dan Siskind, et al.
Published: (2021) -
A longitudinal birth cohort study of child maltreatment and mental disorders using linked statewide child protection and administrative health data for 83,050 Queensland residents from 1983 to 2014
by: Steve Kisely, et al.
Published: (2024) -
Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024)